DUBLIN–()–The “Angelman Syndrome Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s providing.

This report delivers an in-depth understanding of the illness, historic and forecasted Angelman Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Angelman Syndrome Understanding

The Angelman Syndrome epidemiology report provides a radical understanding of the Angelman Syndrome by together with particulars corresponding to illness definition, signs, causes, pathophysiology, and prognosis. It additionally supplies remedy algorithms and remedy tips for Angelman Syndrome in the US, Europe, and Japan. The report covers the detailed data of the Angelman Syndrome epidemiology state of affairs in seven main international locations (US, EU5, and Japan).

Angelman Syndrome Epidemiology Perspective by the writer

The Angelman Syndrome epidemiology division supplies insights about historic and present affected person pool and forecasted development for each seven main international locations. The Angelman Syndrome epidemiology knowledge are studied by means of all potential division to give a greater understanding of the Disease state of affairs in 7MM. The Angelman Syndrome epidemiology section covers the epidemiology knowledge in the US, EU5 international locations (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It additionally helps acknowledge the causes of present and forecasted traits by exploring quite a few research, survey experiences and views of key opinion leaders.

Angelman Syndrome Detailed Epidemiology Segmentation

The Angelman Syndrome epidemiology lined in the report supplies historic in addition to forecasted Angelman Syndrome epidemiology state of affairs in the 7MM overlaying the United States, EU5 international locations (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

The Angelman Syndrome report additionally supplies the epidemiology traits noticed in the 7MM throughout the research interval, together with the assumptions undertaken. The calculated knowledge are introduced with related tables and graphs to give a transparent view of the epidemiology at first sight.

Scope of the Report

  • The Angelman Syndrome report covers an in depth overview explaining its causes, signs, classification, pathophysiology, prognosis and remedy patterns
  • The Angelman Syndrome Epidemiology Report and Model present an outline of the international traits of Angelman Syndrome in the seven main markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
  • The report supplies perception into the historic and forecasted affected person pool of Angelman Syndrome in seven main markets overlaying the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps acknowledge the development alternatives in the 7MM for the affected person inhabitants
  • The report assesses the illness threat and burden and highlights the unmet wants of Angelman Syndrome
  • The report supplies the segmentation of the Angelman Syndrome epidemiology

Report Highlights

  • 11-year Forecast of Angelman Syndrome epidemiology
  • 7MM Coverage
  • Prevalent and Diagnosed Cases of Angelman Syndrome
  • Cases of Angelman Syndrome by Mutation Types
  • Angelman Syndrome Cases related to Clinical Manifestations

Reasons to purchase

  • Develop enterprise methods by understanding the traits shaping and driving the international Angelman Syndrome market
  • Quantify affected person populations in the international Angelman Syndrome market to enhance product design, pricing, and launch plans
  • Organize gross sales and advertising efforts by figuring out the age teams and intercourse that current the finest alternatives for Angelman Syndrome therapeutics in every of the markets lined
  • Understand the magnitude of Angelman Syndrome inhabitants by its epidemiology
  • The Angelman Syndrome Epidemiology Model developed by the writer is straightforward to navigate, interactive with dashboards, and epidemiology based mostly with clear and constant methodologies. Moreover, the mannequin helps knowledge introduced in the report and showcases illness traits over 11-year forecast interval utilizing respected sources

Key Topics Covered:

1. Key Insights

2. Executive Summary of Angelman Syndrome

3. SWOT Analysis for Angelman Syndrome

4. Disease Background and Overview

4.1. Introduction

4.2. Cause

4.3. Signs and Symptoms

4.4. Related Disorders and Differential Diagnosis

4.5. Complications

4.6. Genetics of Angelman syndrome

4.7. Molecular Genetic Pathogenesis

4.8. Diagnosis

4.9. Clinical standards for prognosis

4.10. Disease History and Medical Conditions

4.11. Diagnostic Algorithm

5. Epidemiology and Patient Population

5.1. Key Findings

5.2. 7MM Total Prevalent Patient Population of Angelman syndrome

6. Country Wise-Epidemiology of Angelman syndrome

6.1. The United States

6.2. EU5

6.3. Japan

7. Treatment and Management of Angelman syndrome

7.1. Recommendations for the administration of Angelman Syndrome

7.2. Future remedy choices for Angelman Syndrome

7.2.1. Gene Therapy

7.2.2. Topoisomerase Inhibitors

7.2.3. Minocycline

7.2.4. Cannabidiol (CBD)

7.2.5. Protein Phosphatase 2A (PP2A) Inhibitor

8. Unmet Needs

9. Organizations contributing towards Angelman Syndrome

10. KOL’s Views: Angelman Syndrome

11. Patient Journey

12. Journey towards a Diagnosis: Diagnosing a Rare type of Angelman Syndrome

13. Case Reports

14. Appendix

15. Capabilities

16. Disclaimer

17. About the Publisher

For extra details about this report go to https://www.researchandmarkets.com/r/xkk0d4

Source link